[ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2022, Volume : 15, Issue : 5
First page : ( 2346) Last page : ( 2350)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.52711/0974-360X.2022.00390

A review of genus Garcinia sp as potential sources of therapies against obesity and dyslipidemia

Khutami Chindiana1, Sumiwi Sri Adi1, Muchtaridi Muchtaridi2,*

1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Indonesia

2Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Padjadjaran University, Indonesia

*Corresponding Author E-mail: muchtaridi@unpad.ac.id

Online published on 20 February, 2023.


Obesity is a disease caused by an imbalance of food intake with the energy expended. While dyslipidemia is a complication of lipid disease in the body that can trigger various complications such as cardiovascular disease. Research on antiobesity and antidislipidemia has been done to obtain compounds that can overcome obesity and dyslipidemia because synthetic drugs that have been traded in the community still cause many adverse side effects, one of which is research from the genus Garcinia species. The method for finding reference sources in this review used “Pubmed” database with the keywords "Antiobesity of garcinia", “Antihyperlipidemic OR obesity AND garcinia” and “Obesity OR dyslipidemic AND garcinia”. From the inclusion results, 19 journal articles were discussed in this review. Based on the review results from these reference sources, 9 species of the genus garcinia have activity as antiobesity and antidyslipidemia, namely G. mangostana, G. atroviridis, G. pedunculata, G. dulcis, G. gummi gutta, G. cambogia, G. brasiliensis, G. indica and G. kola.



Garcinia, Obesity, Dyslipidemia.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
755,049,076 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.